Poor, S. M., Henke, M., Ulshöfer, T., Köhm, M., Behrens, F., Burkhardt, H., & Schiffmann, S. (2023). The role of antidrug antibodies in ustekinumab therapy and the impact of methotrexate. Rheumatology, 62(12), 3993. https://doi.org/10.1093/rheumatology/kead177
Chicago Style (17th ed.) CitationPoor, Sorwe Mojtahed, Marina Henke, Thomas Ulshöfer, Michaela Köhm, Frank Behrens, Harald Burkhardt, and Susanne Schiffmann. "The Role of Antidrug Antibodies in Ustekinumab Therapy and the Impact of Methotrexate." Rheumatology 62, no. 12 (2023): 3993. https://doi.org/10.1093/rheumatology/kead177.
MLA (9th ed.) CitationPoor, Sorwe Mojtahed, et al. "The Role of Antidrug Antibodies in Ustekinumab Therapy and the Impact of Methotrexate." Rheumatology, vol. 62, no. 12, 2023, p. 3993, https://doi.org/10.1093/rheumatology/kead177.